Moderate

Pressure ulcer (surgical management)

pressure ulcer · Wounds & Procedures
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Localised skin and soft tissue damage over a bony prominence from sustained pressure/shear, graded by category (I-IV and unstageable). Prevention is paramount; deep ulcers may need debridement, infection control and reconstructive surgery.

Red flags

  • Spreading cellulitis, crepitus or systemic sepsis
  • Exposed bone / probing to bone (osteomyelitis)
  • Rapidly deteriorating wound (necrotising infection)
  • Unstageable ulcer with deep undermining
  • Non-healing chronic ulcer (consider malignancy)

Assessment

Differential diagnosis

  • Pressure ulcer (category I-IV / unstageable)
  • Moisture-associated skin damage
  • Diabetic/neuropathic ulcer
  • Arterial or venous ulcer
  • Necrotising soft tissue infection
  • Malignant (Marjolin) ulcer in chronic wound

Investigations

  • Assess and categorise the ulcer (depth, tissue type, size, undermining)
  • Risk assessment (e.g. Waterlow/Braden score)
  • Wound swab/tissue culture only if clinical infection
  • FBC, CRP, albumin, glucose/HbA1c, U&E
  • X-ray/MRI for suspected underlying osteomyelitis
  • Nutritional screening (MUST)

Management

  • Prevent and treat with the SSKIN bundle (Surface, Skin inspection, Keep moving, Incontinence, Nutrition)
  • Relieve pressure with repositioning schedules and pressure-redistributing mattresses/cushions
  • Categorise the ulcer and document with measurements/photography
  • Optimise nutrition, hydration and glycaemic control
  • Manage moisture and incontinence to protect the skin
  • Debride slough/necrotic tissue (sharp, autolytic or larval) as appropriate
  • Select dressings by wound bed and exudate; consider negative-pressure therapy for deep cavities
  • Treat clinical infection with antibiotics and drainage; investigate osteomyelitis
  • Control pain, especially at dressing changes
  • Refer category III/IV, non-healing or complex ulcers to tissue viability/plastic surgery for possible flap reconstruction
  • Address underlying mobility, continence and comorbidity
  • Monitor healing and reassess the plan regularly

Drugs & doses

Analgesia (paracetamol 1 g PO QDS +/- opioid) including pre-dressing-change
Flucloxacillin 500 mg PO QDS for localised wound infection
Co-amoxiclav 625 mg PO TDS / IV for deeper/mixed infection
Topical antimicrobial dressings (e.g. silver or honey) for critically colonised wounds
Nutritional supplements (high-protein) and micronutrients to support healing

Disposition

Tissue viability nursing and ward/community management; refer category III/IV or complex ulcers to plastic surgery. Admit and escalate for sepsis or necrotising infection.

Complications & pitfalls

  • Osteomyelitis
  • Sepsis
  • Necrotising soft tissue infection
  • Chronic non-healing wound
  • Marjolin's ulcer (malignant transformation)
  • Sinus/fistula formation

Exam pearls

  • Prevention via the SSKIN bundle and repositioning beats treatment — pressure ulcers are largely avoidable
  • Probe-to-bone or exposed bone suggests osteomyelitis
  • Deep (category III/IV) sacral/ischial ulcers may need flap reconstruction after optimisation
  • A chronic non-healing ulcer warrants biopsy to exclude malignancy

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.